LY03020 Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1: 1

Top Sponsors

Luye Pharma Group Ltd.1

Indications

Alzheimer's Disease Psychosis1
Alzheimer's Disease1
Schizophrenia1

Other1 trial

A Phase 1 MAD Study to Evaluate the Safety and Tolerability of LY03020

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.